Clearmind Medicine INC

Form 4F-120-F13G

Insider Trading (Form 4)

NASDAQ
HRT FINANCIAL LP reports a significant transaction involving Clearmind Medicine Inc. Class A Shares.
NASDAQ
HRT FINANCIAL LP reports significant transactions in Clearmind Medicine Inc. common stock.
NASDAQ
HRT FINANCIAL LP reports a transaction involving Clearmind Medicine Inc. common stock.
NASDAQ
HRT Financial LP reported recent open market purchases and sales of Clearmind Medicine Inc. common stock.

Schedule 13G - Passive Investments

See all →
NASDAQ
Iroquois Capital Management, LLC, along with Richard Abbe and Kimberly Page, has disclosed a significant beneficial ownership stake in Clearmind Medicine Inc. through the exercise of warrants, subject to ownership limitations.
NASDAQ
L.I.A. Pure Capital Ltd. has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership stake in Clearmind Medicine Inc.
NASDAQ
L.I.A. Pure Capital Ltd. has reported a 5.0% beneficial ownership stake in Clearmind Medicine Inc., primarily through common shares, a convertible note, and a pre-funded warrant.
NASDAQ
Capitalink Ltd. has reported a 5.0% beneficial ownership stake in Clearmind Medicine Inc., including shares from a convertible note and warrant.
Capital raise
NASDAQ
Iroquois Capital Management, Richard Abbe, and Kimberly Page disclose beneficial ownership of up to 9.99% of Clearmind Medicine Inc. common stock.
NASDAQ
L.I.A. Pure Capital Ltd. reported a 9.97% beneficial ownership stake in Clearmind Medicine Inc. as of December 3, 2025.